Tag: CRON.T
-
Heritage Cannabis (CANN.C) builds CBD extraction facility with JV partner in Oregon
Heritage is now installing extraction and post-production equipment units at Empower’s existing licensed hemp processing facility in Sandy, Oregon, to begin performing “hemp-based product manufacturing for proprietary formulations, tolling services, and third-party white labelling services for other distributors throughout the United States”.
-
Heritage Cannabis (CANN.C) loses $2.3 million in Q4, finds extra year of runway as revenues kick in
A quick scan of headlines today would tell a harrowing story that Heritage Cannabis (CANN.C) was in big trouble and had lost $13 million and pandemonium had broken loose, and dogs and cats were going to be living together any time now. That’s because the company led their Q4 financials news release today with their…
-
SpeakEasy Cannabis (EASY.C) still wants to be Canada’s biggest grow and retail investors are buying it
On the same day mega-grower Cronos Group (CRON.T) said it no longer sees square footage and production capacity as “key performance indicators,” and will cease disclosing them, SpeakEasy Cannabis (EASY.C) put out a surprisingly tone-deaf news release touting its aim to become one of the largest producers in Canada. $CRON basically signaling it isn’t in the…
-
Heritage Cannabis (CANN.C) is ready for Cannabis 2.0, but are you ready for Heritage?
Here at equity.guru, we see the way things are going. Weed stocks are trending down, so we want to highlight companies poised to succeed in the long-term (*cough Cannabis 2.0 *cough). Heritage Cannabis Holdings (CANN.C) is a company which hasn’t gotten the love it deserves lately, and that’s bad. Just look at some of the…
-
Big Tobacco player Altria (MO.NYSE) lobbying hard for hemp, but is it the magic bullet Congress is counting on?
Tobacco giant, Altria Group (MO.NYSE), is lobbying in the United States for “matters pertaining to hemp and crop insurance,” among other things, seemingly aiming to pivot away from vaping amidst a national health emergency. A lobbying report filed by The Russell Group listed its income for the quarter on behalf of Altria as $60,000, a…
-
CIBC’s (CM.T) cannabis coverage: is this Canadian bank a hot mess?
The Canadian Imperial Bank of Commerce CIBC (CM.T) – a $48 billion company with 11 million clients and 40,000 employees – just released a statement declaring that other cannabis industry analysts are lying or deluded about how much weed it is going to sell in the next two years. “Sales estimates for the legal cannabis…
-
Heritage Cannabis (CANN.C) signs monster deal with Cronos (CRON.T)
On July 25, 2019 Heritage Cannabis (CANN.C) announced a vape-device deal with the $6.6 billion Cronos Group (CRON.T). Heritage will fill and package vaporizer devices for the Canadian rec and medical markets. Specifically, vape fulfillment for the Spinach and PEACE NATURALS brands, “utilizing multiple unique and proprietary formulations provided by Cronos Group.” The deal has…
-
Enough is enough: Time for Aphria’s (APHA.T) CEO Vic Neufeld to resign or be fired
It’s time to end the charade. Canadian licensed cannabis producer Aphria (APHA.T) has long been considered one of the ‘big three’ in the North American scene, which helped them benefit from institutional investment, pension fund allocations, and ETF involvement, and contributed to a long rising market cap that topped out in January 2017 at around $5…
-
Sold out: Which Canadian cannabis brands are winning on day one?
Recreational cannabis is legal in Canada, praise Jesus. But anyone who thought pre-rolls would be falling from the sky on day one is living in a fantasy world. Queues are long, stores are already running out of hot sellers, and online traffic is proving hot with looky-loos. Assuming you can find a store that is…
-
Tilray (TLRY.Q) plummets $9.76 after insano run, because shorters are animals
When a new listing goes on a $25 to $95 run in the space of nearly three weeks, the forces of gravity building up over the top of it are always going to collect to breaking point. Observe Tilray (TLRY.Q), which IPOed on the Nasdaq at US$17 per share, and then went on the rip…